ReviewWorld journal of gastroenterology2007
Hepatitis C virus-related lymphoproliferative disorders: an overview.
Review in World journal of gastroenterology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed.
- Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis.European journal of clinical pharmacology · 2010Trial
- Exploring the role of viral hepatitis in plasma cell disorders.Haematologica · 2024Article
- Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection.Cancers · 2023Review
- A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection.Scientific reports · 2022Article
- The Many Faces of Purpura: Vancomycin-Induced Leukocytoclastic Vasculitis.Case reports in infectious diseases · 2021Article
- Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult.The Journal of infectious diseases · 2020Article
- Understanding the Cryoglobulinemias.Current rheumatology reports · 2019Review
- DUBbing Down Translation: The Functional Interaction of Deubiquitinases with the Translational Machinery.Molecular cancer therapeutics · 2019Review
- Late Onset Graft Plasmacytoma-Like PTLD Presenting as Acute Hyperglycemia in a Kidney-Pancreas Transplant Recipient.Case reports in nephrology · 2019Article
- HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents.Frontiers in medicine · 2019Review
- Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?Journal of clinical and experimental hepatology · 2018Review
- The renin angiotensin system in liver and lung: impact and therapeutic potential in organ fibrosis.Journal of lung, pulmonary & respiratory research · 2018Article
- Cryoglobulin Test and Cryoglobulinemia Hepatitis C-Virus Related.Mediterranean journal of hematology and infectious diseases · 2017Review
- Cell culture-derived HCV cannot infect synovial fibroblasts.Scientific reports · 2015Article
- Article
- Extrahepatic manifestations of hepatitis C virus (HCV).Frontline gastroenterology · 2013Article
- Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia.PloS one · 2013Article
- Hepatitis viruses and non-Hodgkin's lymphoma: A review.World journal of virology · 2012Review
- The hepatitis C virus infection as a systemic disease.Internal and emergency medicine · 2012Review
- Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact.Journal of translational medicine · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis C virus (HCV) is a global health problem affecting 3% of the world's population (about 180 million) and a cause of both hepatic and extrahepatic diseases. B-cell lymphoproliferative disorders, whose prototype is mixed cryoglobulinemia, represent the most closely related as well as the most investigated HCV-related extrahepatic disorder. The association between extrahepatic (lymphoma) as well as hepatic malignancies (hepatocellular carcinoma) has justified the inclusion of HCV among human cancer viruses. HCV-associated manifestations also include porphyria cutanea tarda, lichen planus, nephropathies, thyreopathies, sicca syndrome, idiopathic pulmonary fibrosis, diabetes, chronic polyarthritis, sexual dysfunctions, cardiopathy/atherosclerosis, and psychopathological disorders. A pathogenetic link between HCV virus and some lymphoproliferative disorders was confirmed by their responsiveness to antiviral therapy, which is now considered the first choice treatment. The aim of the present paper is to provide an overview of extrahepatic manifestations of HCV infection with particular attention to B-cell lymphoproliferative disorders. Available pathogenetic hypotheses and suggestions about the most appropriate, currently available, therapeutic approaches will also be discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.